Aspirin/Meprobamate

阿司匹林/甲丙氨酯

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAspirin/Meprobamate
Drug Alias Name阿司匹林甲丙氨酯Meprobamate/Aspirin甲丙氨酯阿司匹林Aspirin and Meprobamate甲丙氨酯/阿司匹林 +[9] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptorCyclooxygenases
Therapy Area/IndicationsPain
Global Approved IndicationsPain
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1960/04/15
Country/TerritoryUnited States
CombinationsYes AspirinMeprobamate
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesSun Pharmaceutical Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAh Robins Llc
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN05BC51
Related LinksWikipedia